Stryker Corporation (NYSE:SYK) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Stryker Corporation (NYSE:SYK) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-two ratings firms that are currently covering the firm, Marketbeat Ratings reports. Six research analysts have rated the stock with a hold recommendation and sixteen have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $395.4762.

Several research firms have issued reports on SYK. Leerink Partners began coverage on shares of Stryker in a report on Monday, April 13th. They set an “outperform” rating and a $410.00 price target for the company. Evercore set a $355.00 target price on Stryker in a report on Friday, May 1st. TD Cowen downgraded Stryker from a “buy” rating to a “hold” rating and set a $387.00 target price for the company. in a report on Monday, January 26th. Robert W. Baird set a $385.00 target price on Stryker in a report on Friday, May 1st. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $465.00 target price on shares of Stryker in a report on Wednesday, March 4th.

Insiders Place Their Bets

In other Stryker news, VP M Kathryn Fink sold 3,500 shares of Stryker stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $283.45, for a total value of $992,075.00. Following the completion of the sale, the vice president directly owned 177 shares in the company, valued at approximately $50,170.65. The trade was a 95.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Stryker

A number of hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in Stryker by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 33,907,291 shares of the medical technology company’s stock worth $11,917,396,000 after purchasing an additional 133,892 shares in the last quarter. State Street Corp grew its stake in Stryker by 2.1% in the fourth quarter. State Street Corp now owns 15,254,407 shares of the medical technology company’s stock valued at $5,374,731,000 after acquiring an additional 311,507 shares during the period. Geode Capital Management LLC grew its stake in Stryker by 0.9% in the fourth quarter. Geode Capital Management LLC now owns 7,535,572 shares of the medical technology company’s stock valued at $2,636,238,000 after acquiring an additional 69,851 shares during the period. Wellington Management Group LLP grew its stake in Stryker by 22.6% in the fourth quarter. Wellington Management Group LLP now owns 6,493,276 shares of the medical technology company’s stock valued at $2,282,192,000 after acquiring an additional 1,198,665 shares during the period. Finally, Alliancebernstein L.P. grew its stake in Stryker by 13.3% in the third quarter. Alliancebernstein L.P. now owns 6,338,050 shares of the medical technology company’s stock valued at $2,342,987,000 after acquiring an additional 741,542 shares during the period. 77.09% of the stock is currently owned by institutional investors.

Stryker Stock Up 1.5%

Stryker stock opened at $317.81 on Wednesday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. Stryker has a 52-week low of $281.00 and a 52-week high of $404.87. The firm has a 50 day moving average price of $327.61 and a two-hundred day moving average price of $350.70. The firm has a market cap of $121.84 billion, a price-to-earnings ratio of 36.78, a PEG ratio of 1.97 and a beta of 0.80.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The firm had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. During the same quarter in the previous year, the business posted $2.84 EPS. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Equities analysts predict that Stryker will post 14.98 EPS for the current year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s payout ratio is presently 40.74%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.